scispace - formally typeset
S

Serena Caminito

Researcher at University of Pavia

Publications -  8
Citations -  55

Serena Caminito is an academic researcher from University of Pavia. The author has contributed to research in topics: Amyloidosis & Medicine. The author has an hindex of 2, co-authored 3 publications receiving 15 citations.

Papers
More filters
Journal ArticleDOI

Protease-sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation

TL;DR: This paper identified and compared the fragmentation sites of amyloid light chains (LCs) from multiple organs of an AL-55 patient, including kidney and subcutaneous fat, alongside those previously detected in heart of the same patient, were aligned and mapped on the LC's dimeric and fibrillar states.
Journal ArticleDOI

An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis

TL;DR: In this article , the authors exploited LC sequence information from previously published amyloidogenic and control clonal LCs and from a series of 220 patients with multiple myeloma followed at their Institutions to define sequence and spatial features of N-glycosylation, combining bioinformatics, biochemical, proteomics, structural and genetic analyses.
Journal ArticleDOI

Single‐molecule real‐time sequencing of the M protein: Toward personalized medicine in monoclonal gammopathies

TL;DR: The resulting methodology, termed Single-Molecule Real-Time Sequencing of the M protein (SMaRT M-Seq), identifies the full-length sequence of the variable region of expressed immunoglobulin genes and ranks the obtained sequences based on their relative abundance, thus enabling the identification of thefull-length variable sequence of light and/or heavy chains from a high number of patients analyzed in parallel.
Journal ArticleDOI

AA-amyloidosis in cats (Felis catus) housed in shelters

TL;DR: It is reported that an astonishing 57-73% of early deceased short-hair cats kept in three independent shelters suffer from amyloid deposition in the liver, spleen, or kidney and presence of SAA fragments in bile secretions raises the possibility of fecal-oral transmission of the disease.